D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients

Completed · Phase 2

Conditions studied: Fatigue, Neoplasms

In brief

To evaluate the efficacy of dexmethylphenidate (d-MPH) in the treatment of chemotherapy-related fatigue in adult cancer subjects.

Key facts

Study ID
NCT00047476
Run by
Celgene Corporation
People needed
160
Starts
2002-06-01
Expected to finish
2004-03-01
Last updated by the study team
2005-06-24

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.